Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 years or older
- People with early-stage cervical cancer (FIGO stage IB1) who are not suitable for surgery but can receive combined chemotherapy and radiation treatment
- People with cervical cancer at FIGO stages IB2, IB3, IIA, or IIB
- People with cervical cancer at FIGO stages IIIA or IIIB
- People with FIGO stage IIIC1 cervical cancer where the largest affected lymph node seen on scans is smaller than 3 cm, fewer than 3 lymph nodes appear affected on scans, and no affected nodes are located in the common iliac chain (a specific area near the pelvis)
- People whose cancer type has been confirmed by tissue testing as squamous cell carcinoma, adenocarcinoma, or adenosquamous cell carcinoma of the cervix
- People whose kidneys are functioning well enough to receive a chemotherapy drug called cisplatin, or who may receive an alternative drug called carboplatin if kidney function is reduced but still within an acceptable range (confirm with trial site)
- People who are suitable for a type of internal radiation treatment called brachytherapy
- People who are reasonably well and able to carry out daily activities, with a fitness score of 0, 1, or 2 on a standard medical scale (ECOG performance status)
Who may not be able to join:
- People with cervical cancer at FIGO stages IA, IIIC2, IVA, or IVB
- People with FIGO stage IIIC1 cervical cancer where an affected lymph node is 3 cm or larger, where there are more than 2 suspicious nodes on scans, or where a node is located in the common iliac chain
- People who have previously had radiation treatment to the pelvis or abdomen
- People with active inflammatory bowel disease
- People with an active connective tissue disorder, such as scleroderma or lupus
- People who are unable to have an MRI scan
- People with a fitness score of 3 or higher on the standard medical scale (ECOG performance status), indicating significant limitations in daily activity
- People whose kidneys are not functioning well enough, based on a specific kidney function measurement falling below the minimum threshold required (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +201066760941
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
tumor response rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.